Remedies for recurrent implantation failure

Seminars in Reproductive Medicine

Volumn 32, Issue 4, 2014, Pages 297-305

  Zeyneloglu, Hulusi Bulent ^a   Onalan, Gogsen ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

adjuvant; embryo transfer; implantation; IVF; repeated implantation failure

Indexed keywords

ACETYLSALICYLIC ACID; ANDROGEN; ANTIOXIDANT; ARGININE; CHORIONIC GONADOTROPIN; CORTICOSTEROID; FOLLITROPIN; GLUCOCORTICOID; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH HORMONE; INOSITOL; LOW MOLECULAR WEIGHT HEPARIN; MELATONIN; PENTOXIFYLLINE; PRASTERONE; SILDENAFIL; TESTOSTERONE; UBIDECARENONE; FERTILITY PROMOTING AGENT;

ACUPUNCTURE; ADJUVANT THERAPY; ALTERNATIVE MEDICINE; ARTICLE; BODY MASS; DNA FRAGMENTATION; EMBRYO TRANSFER; FERTILIZATION IN VITRO; GENETIC SCREENING; HATCHING; HERBAL MEDICINE; HUMAN; LIVE BIRTH; META ANALYSIS (TOPIC); NIDATION; OVARIAN RESERVE; OVARY INSUFFICIENCY; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY RATE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT IMPLANTATION FAILURE; TREATMENT FAILURE; DRUG EFFECTS; EVIDENCE BASED MEDICINE; FEMALE; FERTILITY; INFERTILITY; MALE; PATHOPHYSIOLOGY; PREGNANCY; RECURRENT DISEASE;

COMPLEMENTARY THERAPIES; EMBRYO IMPLANTATION; EMBRYO TRANSFER; EVIDENCE-BASED MEDICINE; FEMALE; FERTILITY; FERTILITY AGENTS; FERTILIZATION IN VITRO; HUMANS; INFERTILITY; MALE; PREGNANCY; PREGNANCY RATE; RECURRENCE; TREATMENT FAILURE;

EID: 84902370978     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0034-1375182     Document Type: Article

References (117)

1. Margalioth E. J., Ben-Chetrit A., Gal M., Eldar-Geva T. Investigation and treatment of repeated implantation failure following IVF-ET. Hum Reprod: 2006; 21 12 3036 3043 (Pubitemid 44811601)
2. Simon A., Laufer N. Repeated implantation failure: clinical approach. Fertil Steril: 2012; 97 5 1039 1043
3. Hsu C. J., Hammond J. M. Concomitant effects of growth hormone on secretion of insulin-like growth factor I and progesterone by cultured porcine granulosa cells. Endocrinology: 1987; 121 4 1343 1348 (Pubitemid 17155880)
4. Yoshimura Y., Ando M., Nagamatsu S., et al. Effects of insulin-like growth factor-I on follicle growth, oocyte maturation, and ovarian steroidogenesis and plasminogen activator activity in the rabbit. Biol Reprod: 1996; 55 1 152 160 (Pubitemid 26293152)
5. Mendoza C., Ruiz-Requena E., Ortega E., et al. Follicular fluid markers of oocyte developmental potential. Hum Reprod: 2002; 17 4 1017 1022 (Pubitemid 34411139)
6. Duffy J. M., Ahmad G., Mohiyiddeen L., Nardo L. G., Watson A. Growth hormone for in vitro fertilization. Cochrane Database Syst Rev: 2010; 1 CD000099
7. Kolibianakis E. M., Venetis C. A., Diedrich K., Tarlatzis B. C., Griesinger G. Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update: 2009; 15 6 613 622
8. Eftekhar M., Aflatoonian A., Mohammadian F., Eftekhar T. Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology. Arch Gynecol Obstet: 2013; 287 5 1017 1021
9. Kucuk T., Kozinoglu H., Kaba A. Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial. J Assist Reprod Genet: 2008; 25 4 123 127
10. Bosdou J. K., Venetis C. A., Kolibianakis E. M., et al. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update: 2012; 18 2 127 145
11. Weil S. J., Vendola K., Zhou J., et al. Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab: 1998; 83 7 2479 2485 (Pubitemid 28503050)
12. Hillier S. G., Tetsuka M., Fraser H. M. Location and developmental regulation of androgen receptor in primate ovary. Hum Reprod: 1997; 12 1 107 111 (Pubitemid 27077609)
13. Nielsen M. E., Rasmussen I. A., Kristensen S. G., et al. In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA. Mol Hum Reprod: 2011; 17 1 63 70
14. Sen A., Hammes S. R. Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol: 2010; 24 7 1393 1403
15. Hugues J. N., Durnerin I. C. Impact of androgens on fertility - physiological, clinical and therapeutic aspects. Reprod Biomed Online: 2005; 11 5 570 580 (Pubitemid 41700764)
16. Frattarelli J. L., Peterson E. H. Effect of androgen levels on in vitro fertilization cycles. Fertil Steril: 2004; 81 6 1713 1714 (Pubitemid 38749027)
17. Balasch J., Fábregues F., Peñarrubia J., et al. Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH. Hum Reprod: 2006; 21 7 1884 1893 (Pubitemid 44028265)
18. Casson P. R., Lindsay M. S., Pisarska M. D., Carson S. A., Buster J. E. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum Reprod: 2000; 15 10 2129 2132
19. Mitwally M. F., Casper R. F. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril: 2002; 77 4 776 780 (Pubitemid 34275361)
20. Ferraretti A. P., Gianaroli L., Magli M. C., D'angelo A., Farfalli V., Montanaro N. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril: 2004; 82 6 1521 1526 (Pubitemid 39611376)
21. Berkkanoglu M., Isikoglu M., Aydin D., Ozgur K. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders. Fertil Steril: 2007; 88 3 665 669 (Pubitemid 47368230)
22. Massin N., Cedrin-Durnerin I., Coussieu C., Galey-Fontaine J., Wolf J. P., Hugues J. N. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique-a prospective, randomized, double-blind study. Hum Reprod: 2006; 21 5 1204 1211
23. Kim C. H., Howles C. M., Lee H. A. The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders. Fertil Steril: 2011; 95 2 679 683
24. Gleicher N., Kim A., Weghofer A., et al. Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR). J Assist Reprod Genet: 2013; 30 1 49 62
25. Barad D., Gleicher N. Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum Reprod: 2006; 21 11 2845 2849 (Pubitemid 44566996)
26. Barad D., Brill H., Gleicher N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J Assist Reprod Genet: 2007; 24 12 629 634
27. Mamas L., Mamas E. Premature ovarian failure and dehydroepiandrosterone. Fertil Steril: 2009; 91 2 644 646
28. Gleicher N., Weghofer A., Barad D. H. Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation. Reprod Biomed Online: 2010; 21 3 360 365
29. Yilmaz N., Uygur D., Inal H., Gorkem U., Cicek N., Mollamahmutoglu L. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count. Eur J Obstet Gynecol Reprod Biol: 2013; 169 2 257 260
30. Gleicher N., Weghofer A., Barad D. H. Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS). Reprod Biol Endocrinol: 2010; 8 140
31. Wiser A., Gonen O., Ghetler Y., Shavit T., Berkovitz A., Shulman A. Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod: 2010; 25 10 2496 2500
32. Urman B., Yakin K. DHEA for poor responders: can treatment be justified in the absence of evidence? Reprod Biomed Online: 2012; 25 2 103 107
33. Fleming T. R. Clinical trials: discerning hype from substance. Ann Intern Med: 2010; 153 6 400 406
34. Kara M., Aydin T., Aran T., Turktekin N., Ozdemir B. Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve? Eur J Obstet Gynecol Reprod Biol: 2014; 173 63 65
35. Narkwichean A., Maalouf W., Campbell B. K., Jayaprakasan K. Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis. Reprod Biol Endocrinol: 2013; 11 44
36. Mohsen I. A., El Din R. E. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI. Gynecol Endocrinol: 2013; 29 2 105 108
37. Ozmen B., Sönmezer M., Atabekoglu C. S., Olmus H. Use of aromatase inhibitors in poor-responder patients receiving GnRH antagonist protocols. Reprod Biomed Online: 2009; 19 4 478 485
38. Casanueva F. F., Burguera B., Muruais C., Dieguez C. Acute administration of corticoids: a new and peculiar stimulus of growth hormone secretion in man. J Clin Endocrinol Metab: 1990; 70 1 234 237
39. Kemeter P., Feichtinger W. Prednisolone supplementation to Clomid and/or gonadotrophin stimulation for in-vitro fertilization-a prospective randomized trial. Hum Reprod: 1986; 1 7 441 444 (Pubitemid 17218986)
40. Bider D., Amoday I., Tur-Kaspa I., Livshits A., Dor J. The addition of a glucocorticoid to the protocol of programmed oocyte retrieval for in-vitro fertilization-a randomized study. Hum Reprod: 1996; 11 8 1606 1608 (Pubitemid 26318894)
41. Keay S. D., Lenton E. A., Cooke I. D., Hull M. G., Jenkins J. M. Low-dose dexamethasone augments the ovarian response to exogenous gonadotrophins leading to a reduction in cycle cancellation rate in a standard IVF programme. Hum Reprod: 2001; 16 9 1861 1865 (Pubitemid 32916213)
42. Momeni M., Rahbar M. H., Kovanci E. A meta-analysis of the relationship between endometrial thickness and outcome of in vitro fertilization cycles. J Hum Reprod Sci: 2011; 4 3 130 137
43. Friedler S., Schenker J. G., Herman A., Lewin A. The role of ultrasonography in the evaluation of endometrial receptivity following assisted reproductive treatments: a critical review. Hum Reprod Update: 1996; 2 4 323 335 (Pubitemid 26408112)
44. Sher G., Fisch J. D. Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertil Steril: 2002; 78 5 1073 1076 (Pubitemid 35292511)
45. Weckstein L. N., Jacobson A., Galen D., Hampton K., Hammel J. Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study. Fertil Steril: 1997; 68 5 927 930 (Pubitemid 27506112)
46. Dentali F., Ageno W., Rezoagli E., et al. Low-dose aspirin for in vitro fertilization or intracytoplasmic sperm injection: a systematic review and a meta-analysis of the literature. J Thromb Haemost: 2012; 10 10 2075 2085
47. Groeneveld E., Broeze K. A., Lambers M. J., et al. IPD MARIA study group. Is aspirin effective in women undergoing in vitro fertilization (IVF)? Results from an individual patient data meta-analysis (IPD MA). Hum Reprod Update: 2011; 17 4 501 509
48. Siristatidis C. S., Dodd S. R., Drakeley A. J. Aspirin for in vitro fertilisation. Cochrane Database Syst Rev: 2011; 8 CD004832
49. Groeneveld E., Lambers M. J., Lambalk C. B., et al. Preconceptional low-dose aspirin for the prevention of hypertensive pregnancy complications and preterm delivery after IVF: a meta-analysis with individual patient data. Hum Reprod: 2013; 28 6 1480 1488
50. Lambers M. J., Groeneveld E., Hoozemans D. A., et al. Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy. Hum Reprod: 2009; 24 10 2447 2450
51. Várnagy A., Bódis J., Mánfai Z., Wilhelm F., Busznyák C., Koppán M. Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome. Fertil Steril: 2010; 93 7 2281 2284
52. Nelson S. M., Greer I. A. The potential role of heparin in assisted conception. Hum Reprod Update: 2008; 14 6 623 645
53. Clark P., Walker I. D., Langhorne P., et al. Scottish Pregnancy Intervention Study (SPIN) collaborators. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood: 2010; 115 21 4162 4167
54. Kaandorp S. P., Goddijn M., van der Post J. A., et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med: 2010; 362 17 1586 1596
55. Tan W. K., Lim S. K., Tan L. K., Bauptista D. Does low-molecular-weight heparin improve live birth rates in pregnant women with thrombophilic disorders? A systematic review. Singapore Med J: 2012; 53 10 659 663
56. Potdar N., Gelbaya T. A., Konje J. C., Nardo L. G. Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis. Hum Reprod Update: 2013; 19 6 674 684
57. Seshadri S., Sunkara S. K., Khalaf Y., El-Toukhy T., Hamoda H. Effect of heparin on the outcome of IVF treatment: a systematic review and meta-analysis. Reprod Biomed Online: 2012; 25 6 572 584
58. Akhtar M. A., Sur S., Raine-Fenning N., Jayaprakasan K., Thornton J. G., Quenby S. Heparin for assisted reproduction. Cochrane Database Syst Rev: 2013; 8 CD009452
59. Pountain G. D., Keogan M. T., Hazleman B. L., Brown D. L. Effects of single dose compared with three days' prednisolone treatment of healthy volunteers: contrasting effects on circulating lymphocyte subsets. J Clin Pathol: 1993; 46 12 1089 1092 (Pubitemid 24022952)
60. Hill J. A. Immunological mechanisms of pregnancy maintenance and failure: a critique of theories and therapy. Am J Reprod Immunol: 1990; 22 1-2 33 41
61. Boomsma C. M., Keay S. D., Macklon N. S. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev: 2012; 6 CD005996
62. Gleicher N., Vidali A., Barad D. H. Successful treatment of unresponsive thin endometrium. Fertil Steril: 2011; 95 6 e13 e17
63. Tanaka T., Miyama M., Masuda M., et al. Production and physiological function of granulocyte colony-stimulating factor in non-pregnant human endometrial stromal cells. Gynecol Endocrinol: 2000; 14 6 399 404 (Pubitemid 32165448)
64. Scarpellini F., Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum Reprod: 2009; 24 11 2703 2708
65. Würfel W., Santjohanser C., Hirv K., et al. High pregnancy rates with administration of granulocyte colony-stimulating factor in ART-patients with repetitive implantation failure and lacking killer-cell immunoglobulin-like receptors. Hum Reprod: 2010; 25 8 2151 2152, author reply 2152
66. Gleicher N., Kim A., Michaeli T., et al. A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies. Hum Reprod: 2013; 28 1 172 177
67. Zhao J., Tian T., Zhang Q., Wang Y., Li Y. Use of granulocyte colony-stimulating factor for the treatment of thin endometrium in experimental rats. PLoS ONE: 2013; 8 12 e82375
68. Li Y., Pan P., Chen X., Li L., Li Y., Yang D. Granulocyte Colony-Stimulating Factor Administration for Infertile Women With Thin Endometrium in Frozen Embryo Transfer Program. Reprod Sci: 2014; 21 3 381 385
69. Barad D. H., Yu Y., Kushnir V. A., et al. A randomized clinical trial of endometrial perfusion with granulocyte colony-stimulating factor in in vitro fertilization cycles: impact on endometrial thickness and clinical pregnancy rates. Fertil Steril: 2014; 101 3 710 715
70. Kaufmann S. J., Sharif K., Sharma V., McVerry B. A. Term delivery in a woman with severe congenital neutropenia, treated with growth colony stimulating factor. Hum Reprod: 1998; 13 2 498 499
71. Barash A., Dekel N., Fieldust S., Segal I., Schechtman E., Granot I. Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization. Fertil Steril: 2003; 79 6 1317 1322 (Pubitemid 36687877)
72. Almog B., Shalom-Paz E., Dufort D., Tulandi T. Promoting implantation by local injury to the endometrium. Fertil Steril: 2010; 94 6 2026 2029
73. Karow W. G., Gentry W. C., Skeels R. F., Payne S. A. Endometrial biopsy in the luteal phase of the cycle of conception. Fertil Steril: 1971; 22 8 482 495
74. Raziel A., Schachter M., Strassburger D., Bern O., Ron-El R., Friedler S. Favorable influence of local injury to the endometrium in intracytoplasmic sperm injection patients with high-order implantation failure. Fertil Steril: 2007; 87 1 198 201 (Pubitemid 46019814)
75. El-Toukhy T., Sunkara S., Khalaf Y. Local endometrial injury and IVF outcome: a systematic review and meta-analysis. Reprod Biomed Online: 2012; 25 4 345 354
76. Potdar N., Gelbaya T., Nardo L. G. Endometrial injury to overcome recurrent embryo implantation failure: a systematic review and meta-analysis. Reprod Biomed Online: 2012; 25 6 561 571
77. Hayashi T., Kitaya K., Tada Y., Taguchi S., Funabiki M., Nakamura Y. Single curettage endometrial biopsy injury in the proliferative phase improves reproductive outcome of subsequent in vitro fertilization-embryo transfer cycle in infertile patients with repeated embryo implantation failure. Clin Exp Obstet Gynecol: 2013; 40 3 323 326
78. Karimzadeh M. A., Ayazi Rozbahani M., Tabibnejad N. Endometrial local injury improves the pregnancy rate among recurrent implantation failure patients undergoing in vitro fertilisation/intra cytoplasmic sperm injection: a randomised clinical trial. Aust N Z J Obstet Gynaecol: 2009; 49 6 677 680
79. Mansour R., Tawab N., Kamal O., et al. Intrauterine injection of human chorionic gonadotropin before embryo transfer significantly improves the implantation and pregnancy rates in in vitro fertilization/intracytoplasmic sperm injection: a prospective randomized study. Fertil Steril: 2011; 96 6 1370 1374, e1
80. Licht P., Lösch A., Dittrich R., Neuwinger J., Siebzehnrübl E., Wildt L. Novel insights into human endometrial paracrinology and embryo-maternal communication by intrauterine microdialysis. Hum Reprod Update: 1998; 4 5 532 538 (Pubitemid 29041466)
81. Eftekhar M., Rahmani E., Eftekhar T. Effect of adding human chorionic gonadotropin to the endometrial preparation protocol in frozen embryo transfer cycles. Int J Fertil Steril: 2012; 6 3 175 178
82. Yoshioka S., Fujiwara H., Nakayama T., Kosaka K., Mori T., Fujii S. Intrauterine administration of autologous peripheral blood mononuclear cells promotes implantation rates in patients with repeated failure of IVF-embryo transfer. Hum Reprod: 2006; 21 12 3290 3294 (Pubitemid 44811637)
83. Okitsu O., Kiyokawa M., Oda T., Miyake K., Sato Y., Fujiwara H. Intrauterine administration of autologous peripheral blood mononuclear cells increases clinical pregnancy rates in frozen/thawed embryo transfer cycles of patients with repeated implantation failure. J Reprod Immunol: 2011; 92 1-2 82 87
84. Yang H. W., Hwang K. J., Kwon H. C., Kim H. S., Choi K. W., Oh K. S. Detection of reactive oxygen species (ROS) and apoptosis in human fragmented embryos. Hum Reprod: 1998; 13 4 998 1002 (Pubitemid 28239211)
85. Tamura H., Takasaki A., Miwa I., et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res: 2008; 44 3 280 287 (Pubitemid 351392942)
86. Showell M. G., Brown J., Clarke J., Hart R. J. Antioxidants for female subfertility. Cochrane Database Syst Rev: 2013; 8 CD007807
87. Lu D., Song H., Li Y., Clarke J., Shi G. Pentoxifylline for endometriosis. Cochrane Database Syst Rev: 2012; 1 CD007677
88. Acharya S., Yasmin E., Balen A. H. The use of a combination of pentoxifylline and tocopherol in women with a thin endometrium undergoing assisted conception therapies-a report of 20 cases. Hum Fertil (Camb): 2009; 12 4 198 203
89. Battaglia C., Regnani G., Marsella T., et al. Adjuvant L-arginine treatment in controlled ovarian hyperstimulation: a double-blind, randomized study. Hum Reprod: 2002; 17 3 659 665 (Pubitemid 34232436)
90. Nakamura Y., Tamura H., Takayama H., Kato H. Increased endogenous level of melatonin in preovulatory human follicles does not directly influence progesterone production. Fertil Steril: 2003; 80 4 1012 1016 (Pubitemid 37230040)
91. Batıoǧlu A. S., Sahin U., Gürlek B., Oztürk N., Unsal E. The efficacy of melatonin administration on oocyte quality. Gynecol Endocrinol: 2012; 28 2 91 93
92. Unfer V., Raffone E., Rizzo P., Buffo S. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study. Gynecol Endocrinol: 2011; 27 11 857 861
93. Ostlund R. E. Jr, Seemayer R., Gupta S., Kimmel R., Ostlund E. L., Sherman W. R. A stereospecific myo-inositol/D-chiro-inositol transporter in HepG2 liver cells. Identification with D-chiro-[3-3H]inositol. J Biol Chem: 1996; 271 17 10073 10078
94. Chiu T. T., Rogers M. S., Law E. L., Briton-Jones C. M., Cheung L. P., Haines C. J. Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Hum Reprod: 2002; 17 6 1591 1596 (Pubitemid 34661813)
95. Unfer V., Carlomagno G., Dante G., Facchinetti F. Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecol Endocrinol: 2012; 28 7 509 515
96. Bentov Y., Casper R. F. The aging oocyte-can mitochondrial function be improved? Fertil Steril: 2013; 99 1 18 22
97. Quinzii C. M., Tadesse S., Naini A., Hirano M. Effects of inhibiting CoQ10 biosynthesis with 4-nitrobenzoate in human fibroblasts. PLoS ONE: 2012; 7 2 e30606
98. Gendelman M., Roth Z. Incorporation of coenzyme Q10 into bovine oocytes improves mitochondrial features and alleviates the effects of summer thermal stress on developmental competence. Biol Reprod: 2012; 87 5 118
99. Turi A., Giannubilo S. R., Brugè F., et al. Coenzyme Q10 content in follicular fluid and its relationship with oocyte fertilization and embryo grading. Arch Gynecol Obstet: 2012; 285 4 1173 1176
100. Manheimer E., Zhang G., Udoff L., et al. Effects of acupuncture on rates of pregnancy and live birth among women undergoing in vitro fertilisation: systematic review and meta-analysis. BMJ: 2008; 336 7643 545 549 (Pubitemid 351413280)
101. Smith J. F., Eisenberg M. L., Millstein S. G., et al. Infertility Outcomes Program Project Group. The use of complementary and alternative fertility treatment in couples seeking fertility care: data from a prospective cohort in the United States. Fertil Steril: 2010; 93 7 2169 2174
102. Cheong Y., Nardo L. G., Rutherford T., Ledger W. Acupuncture and herbal medicine in in vitro fertilisation: a review of the evidence for clinical practice. Hum Fertil (Camb): 2010; 13 1 3 12
103. Cao H., Han M., Ng E. H., et al. Can Chinese herbal medicine improve outcomes of in vitro fertilization? A systematic review and meta-analysis of randomized controlled trials. PLoS ONE: 2013; 8 12 e81650
104. Domar A. D., Conboy L., Denardo-Roney J., Rooney K. L. Lifestyle behaviors in women undergoing in vitro fertilization: a prospective study. Fertil Steril: 2012; 97 3 697 701, e1
105. Manheimer E., van der Windt D., Cheng K., et al. The effects of acupuncture on rates of clinical pregnancy among women undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update: 2013; 19 6 696 713
106. Cheong Y. C., Dix S., Hung Yu Ng E., Ledger W. L., Farquhar C. Acupuncture and assisted reproductive technology. Cochrane Database Syst Rev: 2013; 7 CD006920
107. Practice Committee of Society for Assisted Reproductive Technology; Practice Committee of American Society for Reproductive Medicine The role of assisted hatching in in vitro fertilization: a review of the literature. A Committee opinion. Fertil Steril: 2008; 90 (5, Suppl): S196 S198
108. Carney S. K., Das S., Blake D., Farquhar C., Seif M. M., Nelson L. Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI). Cochrane Database Syst Rev: 2012; 12 CD001894
109. Martins W. P., Rocha I. A., Ferriani R. A., Nastri C. O. Assisted hatching of human embryos: a systematic review and meta-analysis of randomized controlled trials. Hum Reprod Update: 2011; 17 4 438 453
110. Cohen J., Alikani M. Evidence-based medicine and its application in clinical preimplantation embryology. Reprod Biomed Online: 2013; 27 5 547 561
111. Fragouli E., Wells D. Aneuploidy screening for embryo selection. Semin Reprod Med: 2012; 30 4 289 301
112. Hardarson T., Hanson C., Lundin K., et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Hum Reprod: 2008; 23 12 2806 2812
113. Debrock S., Melotte C., Spiessens C., et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertil Steril: 2010; 93 2 364 373
114. Mastenbroek S., Twisk M., van der Veen F., Repping S. Preimplantation genetic screening: a systematic review and meta-analysis of RCTs. Hum Reprod Update: 2011; 17 4 454 466
115. Treff N. R., Ferry K. M., Zhao T., Su J., Forman E. J., Scott R. T. Cleavage stage embryo biopsy significantly impairs embryonic reproductive potential while blastocyst biopsy does not: a novel paired analysis of cotransferred biopsied and non-biopsied sibling embryos. Fertil Steril: 2011; 96 S2 S2
116. Yang Z., Liu J., Collins G. S., et al. Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Mol Cytogenet: 2012; 5 1 24
117. Scott R. T. Jr, Upham K. M., Forman E. J., et al. Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertil Steril: 2013; 100 3 697 703